US 11779635
Subcutaneous administration of ADAMTS13
granted A61KA61K38/4886A61K9/0019
Quick answer
US patent 11779635 (Subcutaneous administration of ADAMTS13) held by Takeda Pharmaceutical Company Limited expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/4886, A61K9/0019, A61K9/19, A61P